Quipt Home Medical Corp T.QIPT

longs aren't budging

[gibbonsj]

Huge effort put into driving share price down in advance of financials. Normally that's a bad sign but in this case it's a low volume play to shake shares loose. Longs don't appear to be taking the bait.

[Tropicalsun]

gibbonsj, when you posted last week thinking that we could see the SP approach the $7 to $7.50 range. I thought only if we see news announcing an acquisition of decent size, not looking like that is going to be the case. Yes still time, but super low trading volume.  I would venture a guess at tax loss selling, but this one his hard to figure. Again dissapointing to see the stock price move

[checkup]

Share price is stuck because the Financial report on Thursday will report zero or very low profit.  Following quarters will be profitable.

[Tropicalsun]

And you know this how? Or just your opinion?

[checkup]

Based on several analyst reports.  

[gibbonsj]

Checkup what you say would make sense if it were not for the huge disconnect in volume. Under your scenario I would expect volume to be tenfold what it is.

[lscfa]

  sept qtr will have nice jump in revenues....     $US 000’s Revenue Adj ebitda Dec 22 (e) 41,000 8,610 Sept 22 (e) 40,000 8,400 Jun 22 36,692

[Tropicalsun]

Checkup, have you read the Q4 / 2022 earnings report? Net income of 4.8 million or .13 cents a share as compared to a loss of (6.2) million or (.20) a share in Q4 / 2021. Pretty darn nice turn around I would say.

[Carlito3311]

This post has been removed in accordance with Community Policy

[Carlito3311]

This post has been removed in accordance with Community Policy

[gibbonsj]

Tropical. With volume being what it is it's clear that few are interested in selling. What shares have been traded include a lot of head fakes to bring share price down. Whether that is short covering or patient trading really makes no difference It is very difficult in low volume situations like this to draw any conclusions but the consensus is the company is doing very well and the

[Tropicalsun]

gibbonsj, I agree with your post. I must admit after looking at Iscfa's recent post I am confused with these analysts revenue guidance for calender 2022 year end. Here is what we know, the latest revenue figure stated by the company is around 165 million, again they have maintained their target of between $180 and $190 million revenue run rate by the end of calendar 2022. I don't see how

[lscfa]

 The historical no.s and forecast no.s are for fiscal years, not calender yers.

[gibbonsj]

The target I'm watching is to see if they meet guidance which was based on calendar year. If they need that guidance then all else going forward will be less of a might be prospect and more of a certainty. In order to benefit from the months ahead which you yourself have said will be better in terms of bottom line profits you have to get past this point.

[Tropicalsun]

Right, I get a little confused on calendar and fiscal year end. The end of September 2022 is their fiscal year end and the end of December 2022 is actually the end of Q1 2023, but also end of calendar year 2022. No wonder I get hung up, LOL.